The role of PET radiomic features in prostate cancer: a systematic review

2021 ◽  
Author(s):  
Natale Quartuccio ◽  
Maurizio Marrale ◽  
Riccardo Laudicella ◽  
Pierpaolo Alongi ◽  
Massimiliano Siracusa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review

scholarly journals Diagnostic Role of 18F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review

Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 552
Author(s):  
Salam Awenat ◽  
Arnoldo Piccardo ◽  
Patricia Carvoeiras ◽  
Giovanni Signore ◽  
Luca Giovanella ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Diagnostic Accuracy ◽  
Metastatic Disease ◽  
Cancer Staging ◽  
Relevant Information ◽  
Cochrane Library ◽  
Number Of Patients ◽  
Pet Ct

Background: The use of prostate-specific membrane antigen (PSMA)-targeted agents for staging prostate cancer (PCa) patients using positron emission tomography/computed tomography (PET/CT) is increasing worldwide. We performed a systematic review on the role of 18F-PSMA-1007 PET/CT in PCa staging to provide evidence-based data in this setting. Methods: A comprehensive computer literature search of PubMed/MEDLINE and Cochrane Library databases for studies using 18F-PSMA-1007 PET/CT in PCa staging was performed until 31 December 2020. Eligible articles were selected and relevant information was extracted from the original articles by two authors independently. Results: Eight articles (369 patients) evaluating the role of 18F-PSMA-1007 PET/CT in PCa staging were selected. These studies were quite heterogeneous, but, overall, they demonstrated a good diagnostic accuracy of 18F-PSMA-1007 PET/CT in detecting PCa lesions at staging. Overall, higher primary PCa aggressiveness was associated with higher 18F-PSMA-1007 uptake. When compared with other radiological and scintigraphic imaging methods, 18F-PSMA-1007 PET/CT had superior sensitivity in detecting metastatic disease and the highest inter-reader agreement. 18F-PSMA-1007 PET/CT showed similar results in terms of diagnostic accuracy for PCa staging compared with PET/CT with other PSMA-targeted tracers. Dual imaging with multi-parametric magnetic resonance imaging and 18F-PSMA-1007 PET/CT may improve staging of primary PCa. Notably, 18F-PSMA-1007-PET/CT may detect metastatic disease in a significant number of patients with negative standard imaging. Conclusions: 18F-PSMA-1007 PET/CT demonstrated a good accuracy in PCa staging, with similar results compared with other PSMA-targeted radiopharmaceuticals. This method could substitute bone scintigraphy and conventional abdominal imaging for PCa staging. Prospective multicentric studies are needed to confirm these findings.

scholarly journals The role of CD147 expression in prostate cancer: a systematic review and meta-analysis

2016 ◽  
Vol Volume 10 ◽  
pp. 2435-2442 ◽  
Author(s):  
Yun Ye ◽  
Su-Liang Li ◽  
Yao Wang ◽  
Yao Yang ◽  
Juan Wang ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Meta Analysis ◽  
Cd147 Expression

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer

2019 ◽  
Vol 2 (3) ◽  
pp. 294-301 ◽  
Author(s):  
Eugenio Ventimiglia ◽  
Thomas Seisen ◽  
Firas Abdollah ◽  
Alberto Briganti ◽  
Valerie Fonteyne ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Lymph Node ◽  
Local Treatment ◽  
Node Positive ◽  
Lymph Node Positive

scholarly journals The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature

2017 ◽  
Vol 33 (1) ◽  
pp. 10-21 ◽  
Author(s):  
Barbara Muoio ◽  
Mariarosa Pascale ◽  
Enrico Roggero
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Recent Literature ◽  
Elevated Serum ◽  
Neuron Specific Enolase ◽  
Serum Concentrations ◽  
Castration Resistant ◽  
Comprehensive Search ◽  
Serum Neuron Specific Enolase

In this systematic review, we evaluated the value of serum concentrations of neuron-specific enolase (NSE) in patients with prostate cancer (PCa) in order to clarify the possible role of NSE in the diagnosis, management, treatment and monitoring of PCa. A comprehensive search of the recent literature was conducted to find relevant data on the role of NSE in PCa. Two hundred and eighty-two records were revealed, and 19 articles including 1,772 patients with PCa (either confirmed or suspected) were selected. After reviewing the articles, the major result was that elevated serum NSE appears to correlate with prognosis in advanced PCa, particularly in patients with progressive and metastatic castration-resistant PCa. Based on the existing literature, the role of serum NSE in PCa patients should be further evaluated.

scholarly journals Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review

2016 ◽  
Vol 69 (5) ◽  
pp. 802-820 ◽  
Author(s):  
Roderick C.N. van den Bergh ◽  
Niels J. van Casteren ◽  
Thomas van den Broeck ◽  
Eve R. Fordyce ◽  
William K.M. Gietzmann ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Cancer Patients ◽  
Hormonal Treatment ◽  
Disease Recurrence ◽  
Curative Treatment

The Role of Radical Prostatectomy and Lymph Node Dissection in Lymph Node–Positive Prostate Cancer: A Systematic Review of the Literature

2014 ◽  
Vol 66 (2) ◽  
pp. 191-199 ◽  
Author(s):  
Georgios Gakis ◽  
Stephen A. Boorjian ◽  
Alberto Briganti ◽  
Steven Joniau ◽  
Guram Karazanashvili ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Systematic Review ◽  
Lymph Node ◽  
Radical Prostatectomy ◽  
Lymph Node Dissection ◽  
Review Of The Literature ◽  
Node Dissection ◽  
Node Positive ◽  
Lymph Node Positive
Sign in / Sign up

Export Citation Format

Share Document